Aborted myocardial infarction: Is it real in the troponin era?

Vlad C. Vasile, Luciano Babuin, Henry H. Ting, Malcolm R. Bell, Nicholas M. Orme, Brandon Y. Yuan, Jose A Rio Perez, Jorge R. Alegria, Fernanda Bellolio, Luis H. Haro, Allan S Jaffe

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Cardiac troponins are the markers of choice for the diagnosis of acute myocardial infarction. The objective of this study was to compare the frequency of "aborted myocardial infarction" (no detectable myocardial injury) determined by measurement of troponin versus that determined by creatine kinase (CK) and creatine kinase-muscle brain (CK-MB) measurement criteria among patients with ST-elevation myocardial infarction (STEMI) who received reperfusion therapy. Methods: Since 2004, the Mayo Clinic (Rochester, MN) has had a standard reperfusion protocol for the treatment of patients with STEMI. During the study period, 767 patients presented with new or presumed new ST elevation or left bundle block. Results: The diagnosis of STEMI was confirmed in 765 (99.7%) patients. Using the 99th percentile cutoff value, troponin T elevations occurred in 765 (100%) of 765 patients when serial samples were available. Creatine kinase-MB levels of twice or more the upper limit of normal occurred in 681 (90.1%) of 749 patients with serial samples for CK-MB, and CK equal or greater than twice the gender-specific upper limits of normal occurred in 521 (78.8%) of 661 patients with serial samples for CK available. Conclusion: The frequency of aborted myocardial infarction is 0% when using troponin at the 99th percentile cutoff as recommended by contemporary guidelines from the European Society of Cardiology (Nice, France) and American College of Cardiology (Washington, DC).

Original languageEnglish (US)
Pages (from-to)636-641
Number of pages6
JournalAmerican Heart Journal
Volume157
Issue number4
DOIs
StatePublished - Apr 2009

Fingerprint

Troponin
Myocardial Infarction
Creatine Kinase
MB Form Creatine Kinase
Reperfusion
BB Form Creatine Kinase
MM Form Creatine Kinase
Troponin T
Clinical Protocols
France
Guidelines
Wounds and Injuries
ST Elevation Myocardial Infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Vasile, V. C., Babuin, L., Ting, H. H., Bell, M. R., Orme, N. M., Yuan, B. Y., ... Jaffe, A. S. (2009). Aborted myocardial infarction: Is it real in the troponin era? American Heart Journal, 157(4), 636-641. https://doi.org/10.1016/j.ahj.2008.12.005

Aborted myocardial infarction : Is it real in the troponin era? / Vasile, Vlad C.; Babuin, Luciano; Ting, Henry H.; Bell, Malcolm R.; Orme, Nicholas M.; Yuan, Brandon Y.; Perez, Jose A Rio; Alegria, Jorge R.; Bellolio, Fernanda; Haro, Luis H.; Jaffe, Allan S.

In: American Heart Journal, Vol. 157, No. 4, 04.2009, p. 636-641.

Research output: Contribution to journalArticle

Vasile, VC, Babuin, L, Ting, HH, Bell, MR, Orme, NM, Yuan, BY, Perez, JAR, Alegria, JR, Bellolio, F, Haro, LH & Jaffe, AS 2009, 'Aborted myocardial infarction: Is it real in the troponin era?', American Heart Journal, vol. 157, no. 4, pp. 636-641. https://doi.org/10.1016/j.ahj.2008.12.005
Vasile VC, Babuin L, Ting HH, Bell MR, Orme NM, Yuan BY et al. Aborted myocardial infarction: Is it real in the troponin era? American Heart Journal. 2009 Apr;157(4):636-641. https://doi.org/10.1016/j.ahj.2008.12.005
Vasile, Vlad C. ; Babuin, Luciano ; Ting, Henry H. ; Bell, Malcolm R. ; Orme, Nicholas M. ; Yuan, Brandon Y. ; Perez, Jose A Rio ; Alegria, Jorge R. ; Bellolio, Fernanda ; Haro, Luis H. ; Jaffe, Allan S. / Aborted myocardial infarction : Is it real in the troponin era?. In: American Heart Journal. 2009 ; Vol. 157, No. 4. pp. 636-641.
@article{84ca28cf71b24c79bcb62f96b1cb14ed,
title = "Aborted myocardial infarction: Is it real in the troponin era?",
abstract = "Background: Cardiac troponins are the markers of choice for the diagnosis of acute myocardial infarction. The objective of this study was to compare the frequency of {"}aborted myocardial infarction{"} (no detectable myocardial injury) determined by measurement of troponin versus that determined by creatine kinase (CK) and creatine kinase-muscle brain (CK-MB) measurement criteria among patients with ST-elevation myocardial infarction (STEMI) who received reperfusion therapy. Methods: Since 2004, the Mayo Clinic (Rochester, MN) has had a standard reperfusion protocol for the treatment of patients with STEMI. During the study period, 767 patients presented with new or presumed new ST elevation or left bundle block. Results: The diagnosis of STEMI was confirmed in 765 (99.7{\%}) patients. Using the 99th percentile cutoff value, troponin T elevations occurred in 765 (100{\%}) of 765 patients when serial samples were available. Creatine kinase-MB levels of twice or more the upper limit of normal occurred in 681 (90.1{\%}) of 749 patients with serial samples for CK-MB, and CK equal or greater than twice the gender-specific upper limits of normal occurred in 521 (78.8{\%}) of 661 patients with serial samples for CK available. Conclusion: The frequency of aborted myocardial infarction is 0{\%} when using troponin at the 99th percentile cutoff as recommended by contemporary guidelines from the European Society of Cardiology (Nice, France) and American College of Cardiology (Washington, DC).",
author = "Vasile, {Vlad C.} and Luciano Babuin and Ting, {Henry H.} and Bell, {Malcolm R.} and Orme, {Nicholas M.} and Yuan, {Brandon Y.} and Perez, {Jose A Rio} and Alegria, {Jorge R.} and Fernanda Bellolio and Haro, {Luis H.} and Jaffe, {Allan S}",
year = "2009",
month = "4",
doi = "10.1016/j.ahj.2008.12.005",
language = "English (US)",
volume = "157",
pages = "636--641",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Aborted myocardial infarction

T2 - Is it real in the troponin era?

AU - Vasile, Vlad C.

AU - Babuin, Luciano

AU - Ting, Henry H.

AU - Bell, Malcolm R.

AU - Orme, Nicholas M.

AU - Yuan, Brandon Y.

AU - Perez, Jose A Rio

AU - Alegria, Jorge R.

AU - Bellolio, Fernanda

AU - Haro, Luis H.

AU - Jaffe, Allan S

PY - 2009/4

Y1 - 2009/4

N2 - Background: Cardiac troponins are the markers of choice for the diagnosis of acute myocardial infarction. The objective of this study was to compare the frequency of "aborted myocardial infarction" (no detectable myocardial injury) determined by measurement of troponin versus that determined by creatine kinase (CK) and creatine kinase-muscle brain (CK-MB) measurement criteria among patients with ST-elevation myocardial infarction (STEMI) who received reperfusion therapy. Methods: Since 2004, the Mayo Clinic (Rochester, MN) has had a standard reperfusion protocol for the treatment of patients with STEMI. During the study period, 767 patients presented with new or presumed new ST elevation or left bundle block. Results: The diagnosis of STEMI was confirmed in 765 (99.7%) patients. Using the 99th percentile cutoff value, troponin T elevations occurred in 765 (100%) of 765 patients when serial samples were available. Creatine kinase-MB levels of twice or more the upper limit of normal occurred in 681 (90.1%) of 749 patients with serial samples for CK-MB, and CK equal or greater than twice the gender-specific upper limits of normal occurred in 521 (78.8%) of 661 patients with serial samples for CK available. Conclusion: The frequency of aborted myocardial infarction is 0% when using troponin at the 99th percentile cutoff as recommended by contemporary guidelines from the European Society of Cardiology (Nice, France) and American College of Cardiology (Washington, DC).

AB - Background: Cardiac troponins are the markers of choice for the diagnosis of acute myocardial infarction. The objective of this study was to compare the frequency of "aborted myocardial infarction" (no detectable myocardial injury) determined by measurement of troponin versus that determined by creatine kinase (CK) and creatine kinase-muscle brain (CK-MB) measurement criteria among patients with ST-elevation myocardial infarction (STEMI) who received reperfusion therapy. Methods: Since 2004, the Mayo Clinic (Rochester, MN) has had a standard reperfusion protocol for the treatment of patients with STEMI. During the study period, 767 patients presented with new or presumed new ST elevation or left bundle block. Results: The diagnosis of STEMI was confirmed in 765 (99.7%) patients. Using the 99th percentile cutoff value, troponin T elevations occurred in 765 (100%) of 765 patients when serial samples were available. Creatine kinase-MB levels of twice or more the upper limit of normal occurred in 681 (90.1%) of 749 patients with serial samples for CK-MB, and CK equal or greater than twice the gender-specific upper limits of normal occurred in 521 (78.8%) of 661 patients with serial samples for CK available. Conclusion: The frequency of aborted myocardial infarction is 0% when using troponin at the 99th percentile cutoff as recommended by contemporary guidelines from the European Society of Cardiology (Nice, France) and American College of Cardiology (Washington, DC).

UR - http://www.scopus.com/inward/record.url?scp=62949102688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62949102688&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2008.12.005

DO - 10.1016/j.ahj.2008.12.005

M3 - Article

C2 - 19332189

AN - SCOPUS:62949102688

VL - 157

SP - 636

EP - 641

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 4

ER -